Pinsent Masons advises MedicX Fund on £24.6 million acquisition of Lunn Healthcare Properties portfolio
13 Mar 2014 | 05:16 pm |
International law firm Pinsent Masons has advised MedicX Fund on its £24.6 million acquisition of Lunn Healthcare Properties Ltd comprising a portfolio of nine operational medical centres located across the North of England.
MedicX, a market leading healthcare investor and property developer, has increased its portfolio of properties to 133 primary healthcare properties across the UK.
Pinsent Masons partners Robert Moir and James Long led the team on the deal including Michael Walby, Mark Stephens, Stephen Woods, Carl Scott, Matthew Clayton-Stead and Andrew McCarthy.
Commenting on the deal, Robert Moir said: "We are delighted to have advised MedicX on this important corporate acquisition, which further bolsters the company's strong proposition as a leading healthcare property investor following its very successful equity and debt fundraisings in 2013."
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises Bodymed AG on the sale to Nestlé Health Science
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report
Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.
Pinsent Masons advises shareholders of Goodtill on its sale to SumUp
Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises Bodymed AG on the sale to Nestlé Health Science
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
Pinsent Masons advises shareholders of Goodtill on its sale to SumUp
Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp
Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ
Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]